Cochrane · systematic review · CD000215
Anthelmintics for people with neurocysticercosis
Monk, EJM, Abba, K, Ranganathan, LN · Cochrane Database of Systematic Reviews · 2021 · Cochrane Library
Infectious DiseasesAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
5
current version
GRADE rated
5
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 1 · 20%Low 1 · 20%Moderate 3 · 60%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Albendazole compared with placebo or no anthelmintics for people with neurocysticercosis
Population: people with neurocysticercosis
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Seizure recurrence ‐ all participants Albendazole vs placebo or no anthelmintics | RR 0.94 [0.78, 1.14] | 10 studies · 1054 participants | Low Downgraded: risk of bias, imprecision, inconsistency, indirectness, publication bias |
Seizure recurrence ‐ participants with a single cyst Albendazole vs placebo or no anthelmintics | RR 0.61 [0.4, 0.91] | 5 studies · 396 participants | Moderate Downgraded: risk of bias, imprecision, inconsistency, indirectness, publication bias |
Seizure recurrence ‐ participants with multiple (> 1) cysts Albendazole vs placebo or no anthelmintics | RR 2.05 [1.28, 3.31] | 2 studies · 321 participants | Very low Downgraded: risk of bias, imprecision, inconsistency, indirectness, publication bias |
Complete radiological clearance of lesions Albendazole vs placebo or no anthelmintics | RR 1.22 [1.07, 1.39] | 13 studies · 1324 participants | Moderate Downgraded: risk of bias, imprecision, inconsistency, indirectness, publication bias |
Evolution of cysts Albendazole vs placebo or no anthelmintics | RR 1.27 [1.1, 1.47] | 6 studies · 434 participants | Moderate Downgraded: risk of bias, imprecision, inconsistency, indirectness, publication bias |